A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen - Contacts and Locations

A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

This study is currently recruiting participants.
Information provided by Ludwig Institute for Cancer Research

Please refer to this study by its ClinicalTrials.gov identifier: NCT00623831

Contacts


Contact: Antje Neumann	069 7601-4161	neumann.antje@khnw.de

Locations


Germany
	Krankenhaus Nordwest	Recruiting
	Frankfurt, Germany
	Contact: Antje Neumann 069 7601 4161 neumann.antje@khnw.de
	Principal Investigator: Elke Jaeger, Prof. Dr. med
	Sub-Investigator: Eckhart Weidmann, MD
	Sub-Investigator: Armin Bender, MD

Sponsors and Collaborators

Ludwig Institute for Cancer Research

Investigators


Principal Investigator:	Elke Jaeger, Prof.Dr. med	Krankenhaus Nordwest